Sarepta Therapeutics (SRPT) – Corporate News
-
Sarepta Therapeutics (SRPT) Announces FDA Acceptance of an Efficacy Supplement to Expand the ELEVIDYS Indication
-
Sarepta Therapeutics (SRPT) Announces Positive Data from Part B of MOMENTUM Study
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRPT Stock Lookup